These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug-eluting stents: life insurance with a better death benefit. Anderson HV J Am Coll Cardiol; 2008 May; 51(21):2025-7. PubMed ID: 18498955 [No Abstract] [Full Text] [Related]
3. Value of drug-eluting stents in cardiac transplant recipients. Gupta A; Mancini D; Kirtane AJ; Kaple RK; Apfelbaum MA; Kodali SK; Marboe C; Leon MB; Moses JW; Rabbani LE Am J Cardiol; 2009 Mar; 103(5):659-62. PubMed ID: 19231329 [TBL] [Abstract][Full Text] [Related]
4. [Balloon angioplasty for the treatment of the drug-eluting stent restenosis in a patient with multivessel coronary artery disease and muscular bridge]. Pawłowski T; Kulawik T; Rzezak J Kardiol Pol; 2008 Nov; 66(11):1229-31; discussion 1232. PubMed ID: 19105104 [No Abstract] [Full Text] [Related]
10. [Drug-eluting stents in percutaneous coronary intervention. The Danish Society of Cardiology]. Jensen LO; Thayssen P; Kaltoft AK; Hansen HH; Thuesen L; Ugeskr Laeger; 2008 Mar; 170(12):1019. PubMed ID: 18397637 [No Abstract] [Full Text] [Related]
11. Late in-stent restenosis in a patient with drug-eluting stent. Sultan FA; Kazmi K; Dhakam S; Quraishi AU J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309 [TBL] [Abstract][Full Text] [Related]
12. Multicenter evaluation of percutaneous transluminal coronary angioplasty in heart transplant recipients. Cardiac Transplant Angioplasty Study Group. Halle AA; Wilson RF; Vetrovec GW J Heart Lung Transplant; 1992; 11(3 Pt 2):S138-41. PubMed ID: 1622992 [No Abstract] [Full Text] [Related]
13. Unique challenges of full metal jackets in the era of drug-eluting stents. Ho PC J Invasive Cardiol; 2009 Feb; 21(2):51-2. PubMed ID: 19182290 [No Abstract] [Full Text] [Related]
14. Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery. Sheiban I; Moretti C; Biondi-Zoccai GG; Sciuto F; Omedè P; Lombardi P; Meliga E; Reviglione M; Ballari GP; Bollati M; Gambino A; Trevi G J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):213-6. PubMed ID: 18192822 [No Abstract] [Full Text] [Related]
15. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
16. Cardiac allograft vasculopathy in heart transplant patients: pathologic and clinical aspects for angioplasty/stenting. Kobashigawa JA J Am Coll Cardiol; 2006 Aug; 48(3):462-3. PubMed ID: 16875969 [No Abstract] [Full Text] [Related]
17. Outcome observations with drug-eluting stents. Steffenino G; Olivari Z J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):110-2. PubMed ID: 18192800 [No Abstract] [Full Text] [Related]
18. Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response. Li JJ; Gao RL Chin Med J (Engl); 2009 Mar; 122(6):732-5. PubMed ID: 19323943 [No Abstract] [Full Text] [Related]
19. [A dilemma choosing revascularization method in coronary disease. Drug-eluting stents not a given choice]. Grip L Lakartidningen; 2007 Jun 4-11; 104(23):1774-5. PubMed ID: 17655020 [No Abstract] [Full Text] [Related]
20. Improving long-term outcomes of coronary intervention in patients with diabetes. Shen WF Chin Med J (Engl); 2009 Mar; 122(6):605-7. PubMed ID: 19323918 [No Abstract] [Full Text] [Related] [Next] [New Search]